药物和急性血液溶解在G6PD缺陷患者 - 一个现实世界的研究
Naomi Gronich1,2, Bar Rosh2, Nili Stein1
1Department of Community Medicine and Epidemiology, Lady Davis Carmel Medical Center, Haifa, Israel.
Clinical pharmacology and therapeutics
|June 6, 2024
概括
在现实研究中,许多先前被认为是葡萄糖-6-酸盐脱酶 (G6PD) 缺乏症患者的危险药物被安全地处方. 这一发现为在G6PD缺乏症中安全使用这些药物提供了保证.
科学领域:
- 药物监督 药物监督 药物监督
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
背景情况:
- 药物标签经常警告使用在葡萄糖-6-酸盐脱酶 (G6PD) 缺乏症,由于血解风险.
- 这些警告经常基于有限的临床或流行病学数据.
研究的目的:
- 为了评估G6PD缺乏症患者血液溶解的实际风险,他们处方了可疑具有溶血潜力的药物.
- 为这个患者群体提供关于药物安全性的真实证据.
主要方法:
- 一个大型医疗保健数据库 (Clalit Health Services) 的回顾性分析,包括超过31,000名G6PD缺陷患者.
- 为血液溶解住院的识别和病例的验证.
- 对没有血液溶解的G6PD缺乏患者的药物处方交叉引用.
主要成果:
- 只有0.2%的G6PD缺乏患者经历了严重的血液溶解,其中最常见的原因是豆豆.
- 三例血解病例可能与药物有关 (尼托福兰,费纳索皮里丁,止痛药).
- 许多G6PD缺乏症患者安全地接受了以前被认为具有风险的尼特鲁福兰,西普罗素和硫甲 / 科特里莫克萨等药物.
结论:
- 许多以前标记为G6PD缺乏症的血液溶解风险的药物,在现实实践中使用似乎是安全的.
- 这项研究提供了关键数据,有可能修改药物标签,并为临床处方决策提供信息.
- 结果为患者,医疗保健提供者和监管机构提供了关于G6PD缺乏症药物安全性的保证.
相关概念视频
01:27Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...